- Global Pharma News & Resources

Global Coronavirus Vaccine Market Comprehensions, Trends, Opportunities, Market Growth Rate, Revenue Shares, and Forecast: 2020 to 2027

According to a new report published by Proficient Market, titled, ”Global Coronavirus Vaccine Market by Product Type (Inactivated coronavirus vaccine, Live attenuated coronavirus vaccine, and S-Protein based coronavirus vaccine) and by End-Users/Application (Hospitals, Clinics, Research Institutes, and Others) Global Market Share, Forecast Data, In-Depth Analysis, and Detailed Overview, and Forecast, 2015 – 2027″ The report has offered an all-inclusive analysis of the global coronavirus vaccine market taking into consideration all the crucial aspects like growth factors, constraints, market developments, top investment pockets, future prospects, and trends. At the start, the report lays emphasis on the key trends and opportunities that may emerge in the near future and positively impact the overall industry growth.

According to the report, Global Coronavirus Vaccine Market in 2020 stood at USD XX million and is expected to reach USD XX million by 2027 growing at a CAGR of XX% from 2020 to 2027.

Coronaviruses belongs to a group of virus family that causes illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). It causes infections to mammals as well as birds. However, a novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. Common symptoms associated with coronaviruses infections are from common cold to serious infections and severe respiratory complications, pneumonia, and even kidney failure and death.

Coronaviruses vaccines can treat patients with infection of coronaviruses by inactivating these viruses. Currently, there are no drugs or vaccines approved for treating infected individuals; however, there are several vaccines and drugs in pipeline, and are yet to be approved or launched.

Coronavirus Vaccine Market: Key Players The research study includes profiles of leading companies operating in the global coronavirus vaccine market. Key players profiled in the report include: Moderna Therapeutics, BioCryst Pharmaceuticals, Inc., AbbVie Inc., Gilead Sciences, Johnson & Johnson, Regeneron Pharmaceuticals, Sanofi, Inovio Pharmaceuticals, Inc., Novavax, Inc. and Others.

This Report will help you to understand the Volume, growth with Impacting Trends. Click here To get SAMPLE PDF (Including Full TOC, Table & Figures):

Industrial Dynamics for the Global Coronavirus Vaccine Market: Infection to humans by coronaviruses was first seen in Wuhan City, China. However, this infection has been rapidly spreading across the globe, including North America, Europe, Middle East and Asia. The infection is lethal and proper medication is necessary to treat this infection. The time from development of symptoms of COVID-19 and death has been shown to range between 6 and 41 days, with a median of 14 days. This has prompted an outbreak of activity in a proposal to develop a vaccine. Thus, demand for drugs and other related products is rising exponentially which is boosting the market of coronaviruses vaccines.

Government initiatives on research and development of coronaviruses vaccination is further driving the market of Coronaviruses Vaccines. Factors such as rising population, growing GDP, increasing awareness of coronaviruses, and rising spending on healthcare will create lucrative opportunities for coronaviruses vaccine market in near future. However, high cost involved in research and development of therapeutic drugs and vaccines, and time required for each phase of clinical trials can majorly hamper market growth to some extent.

Region Wise, Global Coronavirus Vaccine Market Analysis: North America is projected to held highest revenue share in the global coronavirus vaccine market, followed by Europe with second-highest revenue share. This can be attributable because of the presence of major players in countries of this region, increasing investments in R&D activities, along with strong support from the government. Revenue from the Asia Pacific market is projected to expand at a significantly highest CAGR owing to the ongoing outbreak 2020 in Wuhan city of China.

Access Full Report, here:

Market Segmentation:

Global Coronavirus Vaccine Market: Product Type analysis
Inactivated coronavirus vaccine
Live attenuated coronavirus vaccine
S-Protein based coronavirus vaccine

Global Coronavirus Vaccine Market: Application analysis
Research Institutes

The report can be customized as per client requirements. For further queries, you can contact us on or +1-773-800-2974. Our executives will be pleased to understand your requirements and offer you the best-suited reports.

Read the full press release and latest news of this report, here:

About Us:
Proficient Market is the leading research company offering both tactical and strategic support to all our customers. Customer satisfaction is our goal and that is why, we have a team of skilled and experienced specialists with the ability to do data mining, information management, and revenue enhancement solutions to ensure that our clients make informed decisions when coming to investing in the market. Our happiness is when we help our clients grow their business, strengthen the brands and educate their members or consumers through the ever-new fun research methods developed by our team.

Contact Us:
Proficient Market
1st Floor, Harikrishna Building,
Samarth Nagar, New Sanghvi,
Pune- 411027 India
Tel: +91-8149441100 (GMT Office Hours)
USA: +17738002974

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us at

Editor Details

Last Updated: 20-Mar-2020